Provexis plc Logo

Provexis plc

PXS.L

(0.5)
Stock Price

0,55 GBp

-117.71% ROA

-61.26% ROE

-22.7x PER

Market Cap.

13.577.700,00 GBp

0% DER

0% Yield

-73.1% NPM

Provexis plc Stock Analysis

Provexis plc Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Provexis plc Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

The stock's ROE indicates a negative return (-15.23%) on shareholders' equity, suggesting poor financial performance.

3 ROA

The stock's ROA (-21.32%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

4 PBV

The stock's high Price-to-Book Value (P/BV) ratio (6.78x) suggests it's overvalued, potentially making it an expensive investment.

5 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Provexis plc Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Provexis plc Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Provexis plc Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Provexis plc Revenue
Year Revenue Growth
2003 75.000
2004 310.000 75.81%
2005 268.000 -15.67%
2006 67.000 -300%
2007 162.000 58.64%
2008 5.000 -3140%
2009 15.000 66.67%
2010 50.000 70%
2011 3.478.000 98.56%
2012 5.559.591 37.44%
2013 3.967 -140045.98%
2014 38.224 89.62%
2015 91.649 58.29%
2016 227.618 59.74%
2017 235.804 3.47%
2018 322.189 26.81%
2019 347.937 7.4%
2020 347.937 0%
2020 505.329 31.15%
2021 426.168 -18.58%
2022 389.916 -9.3%
2023 1.550.136 74.85%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Provexis plc Research and Development Expenses
Year Research and Development Expenses Growth
2003 0
2004 0 0%
2005 394.000 100%
2006 340.000 -15.88%
2007 517.000 34.24%
2008 635.000 18.58%
2009 698.000 9.03%
2010 1.251.000 44.2%
2011 761.000 -64.39%
2012 475.553 -60.02%
2013 142.985 -232.59%
2014 180.497 20.78%
2015 192.236 6.11%
2016 187.163 -2.71%
2017 181.922 -2.88%
2018 229.876 20.86%
2019 251.865 8.73%
2020 251.865 0%
2020 303.898 17.12%
2021 249.694 -21.71%
2022 237.221 -5.26%
2023 560.900 57.71%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Provexis plc General and Administrative Expenses
Year General and Administrative Expenses Growth
2003 883.000
2004 1.916.000 53.91%
2005 2.952.000 35.09%
2006 1.232.000 -139.61%
2007 911.000 -35.24%
2008 847.000 -7.56%
2009 1.061.000 20.17%
2010 1.124.000 5.6%
2011 1.863.000 39.67%
2012 7.322.685 74.56%
2013 879.958 -732.16%
2014 355.964 -147.2%
2015 354.892 -0.3%
2016 446.010 20.43%
2017 489.777 8.94%
2018 557.960 12.22%
2019 455.948 -22.37%
2020 455.948 0%
2020 465.523 2.06%
2021 384.292 -21.14%
2022 426.516 9.9%
2023 964.120 55.76%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Provexis plc EBITDA
Year EBITDA Growth
2003 -850.000
2004 -1.064.000 20.11%
2005 475.000 324%
2006 -1.457.000 132.6%
2007 -1.136.000 -28.26%
2008 -1.491.000 23.81%
2009 -1.682.000 11.36%
2010 -2.313.000 27.28%
2011 -1.656.000 -39.67%
2012 -1.388.471 -19.27%
2013 -1.009.836 -37.49%
2014 -489.097 -106.47%
2015 57.890 944.87%
2016 31.889 -81.54%
2017 19.817 -60.92%
2018 20.871 5.05%
2019 -440.360 104.74%
2020 -406.229 -8.4%
2020 -351.810 -15.47%
2021 -296.220 -18.77%
2022 -437.560 32.3%
2023 69.716 727.63%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Provexis plc Gross Profit
Year Gross Profit Growth
2003 23.000
2004 -160.000 114.38%
2005 92.000 273.91%
2006 67.000 -37.31%
2007 162.000 58.64%
2008 5.000 -3140%
2009 15.000 66.67%
2010 50.000 70%
2011 1.758.000 97.16%
2012 3.141.414 44.04%
2013 3.967 -79088.66%
2014 38.224 89.62%
2015 91.649 58.29%
2016 218.085 57.98%
2017 212.637 -2.56%
2018 272.756 22.04%
2019 312.155 12.62%
2020 312.155 0%
2020 456.193 31.57%
2021 380.049 -20.04%
2022 294.419 -29.08%
2023 550.656 46.53%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Provexis plc Net Profit
Year Net Profit Growth
2003 -855.000
2004 -1.092.000 21.7%
2005 -49.000 -2128.57%
2006 -2.438.000 97.99%
2007 -1.189.000 -105.05%
2008 -4.571.000 73.99%
2009 -1.648.000 -177.37%
2010 -1.984.000 16.94%
2011 -3.873.000 48.77%
2012 -4.338.600 10.73%
2013 488.353 988.41%
2014 -435.598 212.11%
2015 -409.569 -6.36%
2016 -380.087 -7.76%
2017 -448.108 15.18%
2018 -513.032 12.65%
2019 -406.229 -26.29%
2020 -406.229 0%
2020 -341.007 -19.13%
2021 -224.250 -52.07%
2022 -385.241 41.79%
2023 -1.068.424 63.94%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Provexis plc Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Provexis plc Free Cashflow
Year Free Cashflow Growth
2003 -778.000
2004 -1.267.000 38.6%
2005 -2.765.000 54.18%
2006 -2.179.000 -26.89%
2007 -1.585.000 -37.48%
2008 -1.380.000 -14.86%
2009 -1.536.000 10.16%
2010 -2.128.000 27.82%
2011 -2.687.000 20.8%
2012 -1.888.012 -42.32%
2013 -573.344 -229.3%
2014 -404.776 -41.64%
2015 -366.099 -10.56%
2016 -430.302 14.92%
2017 -363.052 -18.52%
2018 -384.014 5.46%
2019 -334.641 -14.75%
2020 -83.760 -299.52%
2020 -262.325 68.07%
2021 -213.787 -22.7%
2022 -519.852 58.88%
2023 -61.471 -745.69%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Provexis plc Operating Cashflow
Year Operating Cashflow Growth
2003 -763.000
2004 -1.265.000 39.68%
2005 -2.749.000 53.98%
2006 -2.179.000 -26.16%
2007 -1.487.000 -46.54%
2008 -1.350.000 -10.15%
2009 -1.500.000 10%
2010 -2.053.000 26.94%
2011 -2.166.000 5.22%
2012 -1.433.348 -51.11%
2013 -573.344 -150%
2014 -404.776 -41.64%
2015 -366.099 -10.56%
2016 -430.302 14.92%
2017 -363.052 -18.52%
2018 -384.014 5.46%
2019 -334.641 -14.75%
2020 -83.760 -299.52%
2020 -262.075 68.04%
2021 -213.537 -22.73%
2022 -519.852 58.92%
2023 -61.471 -745.69%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Provexis plc Capital Expenditure
Year Capital Expenditure Growth
2003 15.000
2004 2.000 -650%
2005 16.000 87.5%
2006 0 0%
2007 98.000 100%
2008 30.000 -226.67%
2009 36.000 16.67%
2010 75.000 52%
2011 521.000 85.6%
2012 454.664 -14.59%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 250 100%
2021 250 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Provexis plc Equity
Year Equity Growth
2003 108.000
2004 510.000 78.82%
2005 8.850.000 94.24%
2006 6.609.000 -33.91%
2007 7.585.000 12.87%
2008 5.532.000 -37.11%
2009 11.062.000 49.99%
2010 11.481.000 3.65%
2011 11.299.000 -1.61%
2012 7.905.872 -42.92%
2013 535.075 -1377.53%
2014 245.899 -117.6%
2015 142.838 -72.15%
2016 24.886 -473.97%
2017 329.260 92.44%
2018 338.888 2.84%
2019 318.681 -6.34%
2020 1.142.188 72.1%
2021 969.080 -17.86%
2022 657.655 -47.35%
2023 190.588 -245.07%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Provexis plc Assets
Year Assets Growth
2003 323.000
2004 1.453.000 77.77%
2005 9.657.000 84.95%
2006 7.448.000 -29.66%
2007 7.946.000 6.27%
2008 5.766.000 -37.81%
2009 11.357.000 49.23%
2010 12.045.000 5.71%
2011 13.415.000 10.21%
2012 10.370.875 -29.35%
2013 643.287 -1512.17%
2014 359.981 -78.7%
2015 256.585 -40.3%
2016 158.200 -62.19%
2017 418.643 62.21%
2018 462.031 9.39%
2019 468.758 1.44%
2020 1.292.869 63.74%
2021 1.126.989 -14.72%
2022 845.992 -33.22%
2023 498.036 -69.87%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Provexis plc Liabilities
Year Liabilities Growth
2003 215.000
2004 943.000 77.2%
2005 807.000 -16.85%
2006 839.000 3.81%
2007 361.000 -132.41%
2008 234.000 -54.27%
2009 295.000 20.68%
2010 564.000 47.7%
2011 2.116.000 73.35%
2012 2.465.003 14.16%
2013 108.212 -2177.94%
2014 114.081 5.14%
2015 113.747 -0.29%
2016 133.314 14.68%
2017 89.383 -49.15%
2018 123.143 27.42%
2019 150.077 17.95%
2020 150.681 0.4%
2021 157.909 4.58%
2022 188.337 16.16%
2023 307.448 38.74%

Provexis plc Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0
Price to Earning Ratio
-22.7x
Price To Sales Ratio
16.93x
POCF Ratio
-69.49
PFCF Ratio
-70.9
Price to Book Ratio
18.37
EV to Sales
16.69
EV Over EBITDA
-22.18
EV to Operating CashFlow
-69.91
EV to FreeCashFlow
-69.91
Earnings Yield
-0.04
FreeCashFlow Yield
-0.01
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0
Graham NetNet
-0

Income Statement Metrics

Net Income per Share
-0
Income Quality
0.33
ROE
-0.61
Return On Assets
-1.18
Return On Capital Employed
-3.17
Net Income per EBT
0.97
EBT Per Ebit
1
Ebit per Revenue
-0.75
Effective Tax Rate
0.02

Margins

Sales, General, & Administrative to Revenue
0.5
Research & Developement to Revenue
0.38
Stock Based Compensation to Revenue
0.15
Gross Profit Margin
0.35
Operating Profit Margin
-0.75
Pretax Profit Margin
-0.75
Net Profit Margin
-0.73

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-0.81
Return on Tangible Assets
-1.18
Days Sales Outstanding
0
Days Payables Outstanding
14.68
Days of Inventory on Hand
96.17
Receivables Turnover
0
Payables Turnover
24.86
Inventory Turnover
3.8
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.31
Current Ratio
1.62
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
190588
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
232158.5
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Provexis plc Dividends
Year Dividends Growth

Provexis plc Profile

About Provexis plc

Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

CEO
Mr. Ian Ford BA (Hons) ACA, F
Employee
2
Address
2 Blagrave Street
Reading, RG1 1AZ

Provexis plc Executives & BODs

Provexis plc Executives & BODs
# Name Age
1 Mr. Ian Ford BA (Hons) ACA, F.C.A.
Chief Executive Officer, Chief Financial Officer, Company Secretary & Executive Director
70
2 Dr. Niamh Ann O'Kennedy B.Sc., BSc, M.Sc., MSc, Ph.D.
Chief Scientific Officer, Member of Scientific Advisory Board & Executive Director
70
3 Prof. Asim K. Duttaroy BS MS Ph.D., DSc FICN
Consultant & Member of Scientific Advisory Board
70

Provexis plc Competitors